Search the whole station

  • EXPANDED ACCESS TO INVESTIGATIONAL DRUGS POLICY

    21

    1. PURPOSE This document describes KOUSAI´s position, and reflects our Corporate Policy on how patients in medical need may be able to access our new medicines before they are fully approved for use on prescription. 2. SCOPE We cover ...

    View details
Expand more!

zh_CN